Targeted Colorectal Cancer Combo Improves QoL
Patients with metastatic colorectal cancer who have the KRAS G12C mutation demonstrated improved quality of life following sotorasib and panitumumab compared with standard therapy.
Source: medscape.com
K Ras News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from K Ras. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In K Ras Today - Breaking & Trending Today
Certain NSCLC Subgroups May Not Benefit From Immunotherapy
A comprehensive study exploring NSCLC subgroup responses to immunotherapy may help determine which patients are less likely to benefit from these agents.
Source: medscape.com
Addressing the Impact of Platinum Shortages in mNSCLC Treatment
Experts address the impact of platinum shortages, 4-cycle platinum chemotherapy, and available treatments beyond platinum chemotherapy.
Source: ajmc.com
FDA Panel Says Amgen Lung Cancer Drug Data Cannot Be Relied on
Advisers to the US Food and Drug Administration on Thursday found that data from a late-stage trial of Amgen's Lumakras could not be relied on.
Source: medscape.com
Adagrasib (Krazati) Approved for KRAS-Mutated NSCLC
It becomes the second KRAS-targeted therapy for use in patients with non–small cell lung cancer (NSCLC) whose tumors have this mutation.
Source: medscape.com